Chemical Industry News, Data & Insights

Terumo Europe's Heverlee Site Named Factory of the Future Again

Key highlights
  • Terumo Europe's Heverlee site is recognized as a Factory of the Future for 2026–2028.
  • The site primarily produces injection needles and solutions for global healthcare.
  • The award is given by Agoria and Sirris for future-focused production.

Recognition and Award

Terumo Europe's production site in Heverlee, Belgium, has been recognized as a Factory of the Future for the period 2026–2028. This title is awarded by Agoria and Sirris, acknowledging the site's continued evolution and commitment to future-focused production.

Production Focus

At the Heverlee location, Terumo primarily manufactures injection needles and injection solutions. These products are essential for healthcare professionals and patients worldwide, aligning with Terumo’s mission to contribute to society through healthcare.

Award Criteria

The Factory of the Future award honors companies that organize their production with a focus on innovation, sustainability, digitalization, technology, efficient processes, and employee development. This recognition confirms Terumo's commitment to these principles.

Commitment to Improvement

The renewed recognition for 2026–2028 highlights the site's dedication to continuous improvement. The state-of-the-art production environment and investment in employee craftsmanship strengthen its role as a reliable partner for the pharmaceutical industry, hospitals, and healthcare professionals.